Eli Lilly (LLY)
844.50
+30.97 (3.81%)
NYSE · Last Trade: Oct 31st, 3:24 AM EDT
Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.
Via Stocktwits · October 31, 2025
Twilio stock rose after the software maker reported Q3 earnings that topped estimates and hiked its full-year revenue outlook.
Via Investor's Business Daily · October 30, 2025
Cloudflare stock wavered after the company reported Q3 earnings that topped estimates and guidance came in slightly above views.
Via Investor's Business Daily · October 30, 2025
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
Via Benzinga · October 30, 2025
Nvidia stock continues to surge higher as the AI chipmaker widens its moat significantly.
Via Barchart.com · October 30, 2025
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY)
 jumped 3.1% in the morning session after the company reported a "beat and raise" quarter. 
Via StockStory · October 30, 2025
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.
Via Investor's Business Daily · October 30, 2025
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Via Benzinga · October 30, 2025
The U.S. stock market opened with a palpable sense of divergence on October 30, 2025, as investors grappled with a mixed bag of quarterly earnings and forward-looking statements from the nation's technology giants. While the venerable Dow Jones Industrial Average (DJIA) managed a modest ascent, both the broader S&
Via MarketMinute · October 30, 2025
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript
Via The Motley Fool · October 30, 2025
Nvidia's $5 trillion valuation record is igniting momentum across semiconductor and AI-themed ETFs as investors chase the next leg of the chip supercycle.
Via Benzinga · October 30, 2025
The Dow Jones Industrial Average (DJIA) finds itself navigating a complex economic landscape as of October 30, 2025, exhibiting resilience despite a barrage of mixed signals from central bank policies, crucial economic data delays, and evolving geopolitical dynamics. Investopedia's analysis points to a market grappling with the Federal Reserve's delicate
Via MarketMinute · October 30, 2025
CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain.
Via Stocktwits · October 30, 2025
Eli Lilly reported Q3 revenue of $17.6 billion, beating estimates and raising 2025 guidance as Mounjaro and Zepbound sales surged.
Via Benzinga · October 30, 2025
Via Benzinga · October 30, 2025
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance.
Via Talk Markets · October 30, 2025
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.
Via Chartmill · October 30, 2025
Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally.
Via Chartmill · October 30, 2025
Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts.
Via Investor's Business Daily · October 30, 2025
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue guidance of $63.25 billion at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $7.02 per share was 18.6% above analysts’ consensus estimates. 
Via StockStory · October 30, 2025
The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive influence of the technology sector, with Artificial Intelligence (AI) at its core. Major U.S. indices, including the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite, have consistently [...]
Via TokenRing AI · October 29, 2025
Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first publicly traded company to reach this staggering valuation. This monumental milestone, reached on Wednesday, October 29, 2025, underscores Nvidia's indispensable role
Via MarketMinute · October 29, 2025
In a historic moment for the technology and financial worlds, Nvidia Corporation (NASDAQ: NVDA) officially achieved an unprecedented $5 trillion market capitalization on Wednesday, October 29, 2025. This landmark valuation, reached during early market trading as shares surged, solidifies Nvidia's position as the world's most valuable company and underscores the profound and accelerating dominance of [...]
Via TokenRing AI · October 29, 2025
